Dr. Allen Lichter talks about Cellworks Biosimulation Technology - Video
SHARE
Treating Cancer needs to go beyond the 'one mutation one drug' paradigm. Watch Cellworks Board Member and former ASCO CEO Dr. Allen Lichter talk about making this possible with Cellworks TRI Reports.